Pervasip Corp. Stock

Equities

PVSP

US7157092005

Internet Services

Market Closed - OTC Markets 02:08:26 2024-04-26 pm EDT 5-day change 1st Jan Change
0.0004 USD 0.00% Intraday chart for Pervasip Corp. 0.00% +33.33%
Sales 2014 491K Sales 2015 605K Capitalization 891K
Net income 2014 - Net income 2015 - EV / Sales 2014 11.3 x
Net Debt 2014 5.43M Net Debt 2015 4.51M EV / Sales 2015 8.93 x
P/E ratio 2014
-0.21 x
P/E ratio 2015
6.41 x
Employees 3
Yield 2014 *
-
Yield 2015
-
Free-Float 48.48%
More Fundamentals * Assessed data
Dynamic Chart
1 week
0.00
Extreme 0.0003
0.00
1 month
0.00
Extreme 0.0003
0.00
Current year
0.00
Extreme 0.0001
0.00
1 year
0.00
Extreme 0.0001
0.00
3 years
0.00
Extreme 0.0001
0.01
5 years
0.00
Extreme 0
0.04
10 years
0.00
Extreme 0
0.04
More quotes
Managers TitleAgeSince
Chief Executive Officer - 21-12-05
Director of Finance/CFO - 22-01-05
More insiders
Date Price Change Volume
24-04-26 0.0004 0.00% 10,000
24-04-25 0.0004 0.00% 1,305,569
24-04-24 0.0004 0.00% 1,224,616
24-04-23 0.0004 +33.33% 14,923,310
24-04-22 0.0003 -25.00% 11,276,064

Delayed Quote OTC Markets, April 26, 2024 at 02:08 pm EDT

More quotes
Pervasip Corp. is engaged in consulting, IP licensing, management, staffing, leasing, and support services. The Company is a diversified asset management company. It acquires, develops, and supports companies and technologies in the emerging cannabis industry. It also owns the rights to multiple cannabis brands. The Company owns Artizen Corporation (Artizen Corp). Artizen Corp’s wholly owned subsidiary, Zen Asset Management LLC (ZAM), is a foundational operator that provides the basis for its cannabis-related investments. ZAM is a diversified asset management company. It also invested in a small Korea-based research entity, KRTL, to establish an early foothold in the rapidly expanding world of medical fungi, with a specific focus on Psilocybin.
More about the company